| 1 |
34680049 | HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation. | 2021 Sep 28 |
2 |
| 2 |
32173476 | Different Drugs Effect on Mesenchymal Stem Cells Isolated From Abdominal Aortic Aneurysm. | 2020 Aug |
3 |
| 3 |
32421147 | Statins Suppress TGF-β2-Mediated MMP-2 and MMP-9 Expression and Activation Through RhoA/ROCK Inhibition in Astrocytes of the Human Optic Nerve Head. | 2020 May 11 |
1 |
| 4 |
33250768 | Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1. | 2020 |
1 |
| 5 |
31260663 | Effects of simvastatin on matrix metalloproteinase regulation in IL-1β-induced SW1353 cells. | 2019 Sep 1 |
1 |
| 6 |
28390432 | Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease. | 2017 Apr 8 |
3 |
| 7 |
26988924 | Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis. | 2016 Jul |
1 |
| 8 |
25704622 | The Effect of Simvastatin on Infection-Induced Inflammatory Response of Human Fetal Membranes. | 2015 Jul |
1 |
| 9 |
25800096 | The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue. | 2015 May |
2 |
| 10 |
25993292 | Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue. | 2015 May 18 |
2 |
| 11 |
24233024 | Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products. | 2014 Mar |
2 |
| 12 |
24506800 | Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment. | 2014 Nov |
1 |
| 13 |
24684779 | Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome. | 2014 Mar 31 |
1 |
| 14 |
25316568 | Simvastatin induces NFκB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells. | 2014 Dec 15 |
7 |
| 15 |
25432084 | Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide. | 2014 Nov 29 |
1 |
| 16 |
23913656 | Simvastatin therapy decreases MMP-9 levels in obese women. | 2013 Oct |
4 |
| 17 |
23924855 | Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells. | 2013 |
2 |
| 18 |
20946258 | Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal. | 2012 Apr |
1 |
| 19 |
21448567 | Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. | 2011 Jun |
2 |
| 20 |
19299917 | Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract. | 2009 Apr 30 |
2 |
| 21 |
19589242 | Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction. | 2009 May-Jun |
1 |
| 22 |
18326912 | [Quantitative ultrasonic integrated backscatter of the intima-media complex, serum level of matrix metalloprotease-9 and simvastatin in hyperlipemia patients]. | 2008 Feb |
3 |
| 23 |
18625914 | Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation. | 2008 Oct |
1 |
| 24 |
17560598 | Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. | 2007 Aug |
3 |
| 25 |
17574455 | Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. | 2007 Sep |
1 |
| 26 |
16386257 | Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins. | 2006 Nov |
4 |
| 27 |
16741180 | Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes. | 2006 Jul |
2 |
| 28 |
17184595 | Simvastatin could prevent increase of the serum MMP-9/TIMP-1 ratio in acute ischaemic stroke. | 2006 |
3 |
| 29 |
15728660 | Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. | 2005 May |
6 |
| 30 |
16465063 | HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins. | 2005 Nov-Dec |
3 |
| 31 |
15107580 | Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells. | 2004 Apr |
4 |
| 32 |
15210533 | Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases. | 2004 Jun |
2 |
| 33 |
15458690 | Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia. | 2004 Nov |
1 |
| 34 |
15537504 | Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. | 2004 Dec 1 |
3 |
| 35 |
15706857 | [Effects of Astragalus and saponins of Panax notoginseng on MMP-9 in patients with type 2 diabetic macroangiopathy]. | 2004 Mar |
1 |
| 36 |
12659988 | Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. | 2003 Mar |
2 |
| 37 |
12023838 | Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9. | 2002 Apr |
1 |
| 38 |
12096273 | Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. | 2002 Jul |
1 |
| 39 |
11428539 | Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet. | 2001 Jun |
3 |